High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.

[1]  R. Moreira,et al.  Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil , 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  R. Moreira,et al.  Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C , 2018, Memorias do Instituto Oswaldo Cruz.

[3]  M. Moghadami,et al.  Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users , 2017, Virology Journal.

[4]  B. Walker,et al.  HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Hughes,et al.  Multiple Origins of Virus Persistence during Natural Control of HIV Infection , 2016, Cell.

[6]  L. Ratner,et al.  Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles. , 2016, Virology.

[7]  Jeffrey N. Martin,et al.  Immunologic profiles distinguish aviremic HIV-infected adults , 2016, AIDS.

[8]  Felipe García,et al.  Rate and predictors of progression in elite and viremic HIV-1 controllers , 2016, AIDS.

[9]  Felipe García,et al.  Analysis of Non-AIDS-Defining Events in HIV Controllers. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Duracinsky,et al.  Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study) , 2015, Expert review of gastroenterology & hepatology.

[11]  C. Quereda,et al.  Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy , 2015, AIDS.

[12]  Jeffrey N. Martin,et al.  A closer look at hepatitis C clearance in HIV controllers: a response. , 2014, AIDS.

[13]  G. Lauer,et al.  The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection , 2014, Hepatology.

[14]  A. De Maria,et al.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status , 2013, Front. Microbiol..

[15]  L. Ruiz,et al.  Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses , 2013, PloS one.

[16]  C. Sabin,et al.  Natural history of HIV-control since seroconversion , 2013, AIDS.

[17]  A. Folgori,et al.  Treatment optimization and prediction of HCV clearance in patients with acute HCV infection. , 2013, Journal of hepatology.

[18]  L. Brigido,et al.  Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians. , 2013, AIDS research and human retroviruses.

[19]  Ling Lu,et al.  Correlation of Viral Loads with HCV Genotypes: Higher Levels of Virus Were Revealed among Blood Donors Infected with 6a Strains , 2012, PloS one.

[20]  O. Lambotte,et al.  HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term , 2012, Journal of Virology.

[21]  V. Soriano,et al.  Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain , 2012, Virology Journal.

[22]  M. Beilke.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research. , 2012, AIDS research and human retroviruses.

[23]  E. Ruiz-Mateos,et al.  Hepatitis C virus replication in Caucasian HIV controllers , 2011, Journal of viral hepatitis.

[24]  O. Lambotte,et al.  Epidemiology and clinical characteristics of elite controllers , 2011, Current opinion in HIV and AIDS.

[25]  C. Rouzioux,et al.  CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory , 2011, PloS one.

[26]  S. Moreno,et al.  HTLV-2b among HIV type 1-coinfected injecting drug users in Spain. , 2010, AIDS research and human retroviruses.

[27]  R. Redfield,et al.  Hepatitis C infection in HIV-1 natural viral suppressors , 2010, AIDS.

[28]  R. Siliciano,et al.  Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus , 2010, Journal of Virology.

[29]  B. Agan,et al.  Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. , 2009, The Journal of infectious diseases.

[30]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[31]  C. Rouzioux,et al.  Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 , 2009, The Journal of Immunology.

[32]  A. Mocroft,et al.  Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. , 2008, The Journal of infectious diseases.

[33]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[34]  J. Goedert,et al.  Hepatitis C virus load and survival among injection drug users in the United States , 2005, Hepatology.

[35]  C. Rouzioux,et al.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  A. Geretti,et al.  Human T‐cell lymphotropic virus antibody prevalence in HIV‐1‐infected individuals attending a sexual health clinic in South‐East London , 2005, Journal of medical virology.

[37]  H. Doerr,et al.  Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection , 1996, Journal of medical virology.

[38]  J. Guerreiro,et al.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2 , 1996, Journal of virology.

[39]  Jeffrey N. Martin,et al.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.